Almost one in four older adults with less-than-optimal well-being at baseline regained well-being over approximately three years
Benefits seen in health-related quality of life and anxiety
Study shows sustained remission five years posttreatment
Psychosocial symptoms improved with encounters with behavioral health clinician, psychotropic prescriptions
Receipt of MOUD in jail linked to lower postrelease risks for fatal overdose, nonfatal overdose, reincarceration
Higher prevalence of structural brain abnormalities and increased occurrence of interictal epileptiform discharges observed
The move comes as regulators increase scrutiny of chatbots and their impact on young people’s mental health
Clinically significant reduction in psychological distress seen at three months with digital intervention
Largest increase seen in women aged 25 to 34 years
Sales are a fraction of pharmacy-dispensed and program-distributed naloxone









